Side population cells and drug resistance in breast cancer

被引:38
作者
Wang, Meijian [1 ]
Wang, Yaqi [1 ]
Zhong, Jun [1 ]
机构
[1] Jiangxi Prov Tumor Hosp, Dept Oncol, Nanchang 330029, Jiangxi, Peoples R China
关键词
cancer stem cells; side population; transporters; multi-drug resistance; chemotherapy; MAMMARY-GLAND; EXPRESSION; THERAPY; TARGETS;
D O I
10.3892/mmr.2015.3291
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several studies have demonstrated that the isolated side population (SP) cells from solid tumors exhibit cancer stem cell-like properties, and are responsible for drug resistance during chemotherapy and tumor recurrence. In the current study, cancer stem cell-like SP cells were isolated in the MDU-22 breast cancer cell line using the Hoechst-33342 dye exclusion technique. It was observed that SP cells accounted for 3.8% of cells in the MDU-22 cell line, which was reduced to 0.6% in the presence of verapamil, an inhibitor of the ABC transporter. The sorted SP cells showed an elevated expression of stem cell markers, including ABCG2,OCT-4 and EpCAM. Furthermore, it was demonstrated that the isolated SP cells undergo rapid proliferation and have a high survival rate. These results indicate that the coexpression of adenosine triphosphatase binding cassette transporters and stem cell surface markers in SP cells may contribute to chemoresistance, tumor recurrence, metastasis and invasion. Therefore, the isolation and characterization of SP cells may provide novel insights for the development of alternative therapeutic agents to target cancer stem cells.
引用
收藏
页码:4297 / 4302
页数:6
相关论文
共 19 条
[11]   Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line [J].
Kondo, T ;
Setoguchi, T ;
Taga, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (03) :781-786
[12]   Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling [J].
Nakanishi, T. ;
Chumsri, S. ;
Khakpour, N. ;
Brodie, A. H. ;
Leyland-Jones, B. ;
Hamburger, A. W. ;
Ross, D. D. ;
Burger, A. M. .
BRITISH JOURNAL OF CANCER, 2010, 102 (05) :815-826
[13]   Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic [J].
Patrawala, L ;
Calhoun, T ;
Schneider-Broussard, R ;
Zhou, JJ ;
Claypool, K ;
Tang, DG .
CANCER RESEARCH, 2005, 65 (14) :6207-6219
[14]   Multidrug resistance review in human tumors - Molecular diagnosis and clinical significance [J].
Ramachandran, C ;
Melnick, SJ .
MOLECULAR DIAGNOSIS, 1999, 4 (02) :81-94
[15]   Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1® [J].
Robey, Robert W. ;
Shukla, Suneet ;
Finley, Elizabeth M. ;
Oldham, Robert K. ;
Barnett, Daryl ;
Ambudkar, Suresh V. ;
Fojo, Tito ;
Bates, Susan E. .
BIOCHEMICAL PHARMACOLOGY, 2008, 75 (06) :1302-1312
[16]   Quantitative Mass Spectrometry Identifies Drug Targets in Cancer Stem Cell-Containing Side Population [J].
Steiniger, Sebastian C. J. ;
Coppinger, Judith A. ;
Krueger, Joerg A. ;
Yates, John, III ;
Janda, Kim D. .
STEM CELLS, 2008, 26 (12) :3037-3046
[17]   Sca-1pos cells in the mouse mammary gland represent an enriched progenitor cell population [J].
Welm, BE ;
Tepera, SB ;
Venezia, T ;
Graubert, TA ;
Rosen, JM ;
Goodell, MA .
DEVELOPMENTAL BIOLOGY, 2002, 245 (01) :42-56
[18]   Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy [J].
Yanamoto, Souichi ;
Kawasaki, Goro ;
Yoshitomi, Izumi ;
Iwamoto, Tsutomu ;
Hirata, Kazunari ;
Mizuno, Akio .
ORAL ONCOLOGY, 2007, 43 (09) :869-877
[19]   Isolation and characterization of cancer stem-like side population cells in human oral cancer cells [J].
Yanamoto, Souichi ;
Kawasaki, Goro ;
Yamada, Shin-ichi ;
Yoshitomi, Izumi ;
Kawano, Toshihiro ;
Yonezawa, Hisanobu ;
Rokutanda, Satoshi ;
Naruse, Tomofumi ;
Umeda, Masahiro .
ORAL ONCOLOGY, 2011, 47 (09) :855-860